CRIS Current Research Information System

PASQUALI, RENATO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.583
EU - Europa 7.464
AS - Asia 6.545
SA - Sud America 627
AF - Africa 449
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 8
Totale 26.689
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.487
GB - Regno Unito 2.353
SG - Singapore 2.093
CN - Cina 1.903
VN - Vietnam 1.300
IT - Italia 997
DE - Germania 930
SE - Svezia 890
BR - Brasile 491
HK - Hong Kong 489
RU - Federazione Russa 475
UA - Ucraina 467
IN - India 407
FR - Francia 373
IE - Irlanda 280
ZA - Sudafrica 198
EE - Estonia 162
CH - Svizzera 114
JP - Giappone 110
TG - Togo 108
FI - Finlandia 97
NL - Olanda 84
KR - Corea 68
BG - Bulgaria 65
CI - Costa d'Avorio 58
AR - Argentina 57
CA - Canada 49
BE - Belgio 47
SC - Seychelles 36
JO - Giordania 32
AT - Austria 31
EC - Ecuador 28
GR - Grecia 24
MX - Messico 24
IR - Iran 22
NG - Nigeria 22
ID - Indonesia 21
TR - Turchia 15
BD - Bangladesh 14
CL - Cile 14
ES - Italia 14
IQ - Iraq 14
PL - Polonia 14
PY - Paraguay 14
AU - Australia 11
LB - Libano 10
RO - Romania 10
HN - Honduras 9
CO - Colombia 8
KZ - Kazakistan 8
UZ - Uzbekistan 8
MA - Marocco 7
PE - Perù 7
EU - Europa 6
MY - Malesia 6
CZ - Repubblica Ceca 5
EG - Egitto 5
HR - Croazia 5
PT - Portogallo 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
LT - Lituania 4
MD - Moldavia 4
PK - Pakistan 4
VE - Venezuela 4
BZ - Belize 3
DO - Repubblica Dominicana 3
KW - Kuwait 3
NO - Norvegia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CY - Cipro 2
ET - Etiopia 2
GE - Georgia 2
IL - Israele 2
KG - Kirghizistan 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PH - Filippine 2
RS - Serbia 2
SN - Senegal 2
BF - Burkina Faso 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
DK - Danimarca 1
DZ - Algeria 1
FK - Isole Falkland (Malvinas) 1
GA - Gabon 1
GH - Ghana 1
GY - Guiana 1
HU - Ungheria 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MK - Macedonia 1
ML - Mali 1
Totale 26.683
Salva come PNG Salva come JPEG
Città #
Southend 2.131
Ashburn 1.505
Fairfield 1.492
Singapore 1.286
Woodbridge 711
Wilmington 676
Seattle 663
Chandler 660
Houston 602
Hong Kong 482
Cambridge 472
Santa Clara 425
Princeton 415
Dong Ket 410
Ann Arbor 373
Jacksonville 306
Dublin 279
Beijing 268
Boardman 237
Bologna 230
Nanjing 200
Westminster 194
Padova 181
Ho Chi Minh City 174
Hefei 164
Hanoi 123
Los Angeles 123
Berlin 122
Lomé 108
Tokyo 106
Buffalo 103
Shenyang 102
Saint Petersburg 100
Jinan 97
Bern 92
San Diego 91
Helsinki 75
New York 74
Seoul 66
Sofia 64
Nanchang 63
Mülheim 61
Redondo Beach 60
Abidjan 58
Guangzhou 58
Changsha 57
Hebei 57
Milan 56
Tianjin 51
Dallas 50
Bremen 46
São Paulo 46
Redwood City 39
Turin 38
Brussels 37
Chicago 37
Falls Church 36
Dearborn 34
Jiaxing 34
Norwalk 34
Olalla 34
Shanghai 33
Amman 32
Medford 31
Redmond 31
Hangzhou 30
Yubileyny 30
Zhengzhou 30
Munich 29
Des Moines 27
Mahé 25
Frankfurt am Main 23
Haikou 23
Haiphong 23
Abeokuta 22
Phoenix 22
Florence 21
Taizhou 21
Naples 20
Ningbo 20
The Dalles 20
Verona 20
Rome 19
San Venanzo 19
Taiyuan 19
Vienna 19
Xi'an 19
Toronto 18
Ha Long 17
Lanzhou 17
London 17
Bengaluru 16
Hyderabad 16
Falkenstein 15
Kuban 15
Stockholm 15
Da Nang 14
Rio de Janeiro 14
Boston 13
Johannesburg 13
Totale 17.796
Salva come PNG Salva come JPEG
Nome #
Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society 560
Predictors of weight loss and maintenance in patients treated with antiobesity drugs. 498
Defining hyperandrogenism in women with polycystic ovary syndrome: A challenging perspective 253
Centenarians’ offspring as a model of healthy aging: a reappraisal of the data on Italian subjects and a comprehensive overview 236
Behavioral, socio-environmental, educational and demographic correlates of excess body weight in Italian adolescents and young adults 225
Insulin sensitizers in polycystic ovary syndrome 222
Can imaging predict subclinical cortisol secretion in patients with adrenal adenomas? A CT predictive score 219
Active and total ghrelin concentrations in the newborn 215
Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study. 210
Heterogeneity of thyroid function and impact of peripheral thyroxine deiodination in centenarians and semi-supercentenarians: association with functional status and mortality. 210
17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome. 208
The potential role of increased adrenal volume in the pathophysiology of obesity-related type 2 diabetes. 207
Acyl ghrelin and metabolic hormones in pregnant and lactating sows. 204
Il sistema endocannabinoide e il controllo del metabolismo energetico: fisiologia e fisiopatologia 202
Aldosterone and type 2 diabetes mellitus 200
Androgen Profiling by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) in Healthy Normal-Weight Ovulatory and Anovulatory Late Adolescent and Young Women 198
Clomiphene citrate effect in obese men with low serum testosterone treated with metformin due to dysmetabolic disorders: A randomized, double-blind, placebo-controlled study 197
11C-meta-hydroxyephedrine PET/CT imaging allows in vivo study of adaptive thermogenesis and white-to-brown fat conversion 195
CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance. 194
Acute severe male hypo-testosteronemia affects central motor command in humans 194
A combination of polymorphisms in HSD11B1 associates with in vivo 11{beta}-HSD1 activity and metabolic syndrome in women with and without polycystic ovary syndrome. 193
New insights on diabetes in Turner syndrome: results from an observational study in adulthood 190
Combined Aldosterone and Cortisol Secretion by Adrenal Incidentaloma 188
Plasma 2-arachidonoylglycerol is a biomarker of age and menopause related insulin resistance and dyslipidemia in lean but not in obese men and women 187
Whole Exome Sequencing Uncovers Germline Variants of Cancer-Related Genes in Sporadic Pheochromocytoma 186
Body mass index-independent metabolic alterations in narcolepsy with cataplexy. 183
A new interaction to come: Ghrelin and steroid hormones 182
Profiling plasma N-Acylethanolamine levels and their ratios as a biomarker of obesity and dysmetabolism 182
Endocrine dysfunction in hereditary hemochromatosis 180
A comprehensive approach in diagnosing the polycystic ovary syndrome 178
The negative association between total ghrelin levels, body mass and insulin secretion is lost in hypercortisolemic patients with Cushing's disease. 172
Short-term modification of sex hormones is associated with changes in ghrelin circulating levels in healthy normal-weight men. 172
A placebo controlled, randomized clinical trial using testosterone undecanoate with injectable norethisterone enanthate: effects on anthropometric, metabolic and biochemical parameters 171
Cortisol, energy intake, and food frequency in overweight/obese women 171
The Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk 169
Circulating endocannabinoids are differentially modulated during the oral glucose tolerance test 167
Anti-müllerian hormone and insulin-like 3 levels in healthy normal-weight ovulatory and anovulatory eumenorrheic late adolescent females: potential early biomarkers of ovarian dysfunction? 166
Dietary habits and their relationship with hormones and metabolism in overweight and obese women with polycystic ovary syndrome 164
The endocannabinoid system and the treatment of obesity. 163
Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study. 162
The Significance of Low Testosterone Levels in Obese Men 162
Organic cation transporter 1 polymorphisms predict the metabolic response to metformin in women with the polycystic ovary syndrome. 160
Relationships between total and regional adiposity and epicardial fat in obese women: how can dual-energy X-ray absorptiometry be associated with echocardiographic epicardial fat measurements? 160
Steroid biomarkers for identifying non-classic adrenal hyperplasia due to 21-hydroxylase deficiency in a population of PCOS with suspicious levels of 17OH-progesterone 159
Cannabinoid type 1 receptor: another arrow in the adipocytes' bow 158
Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome. 157
Tablet and oral liquid L-thyroxine formulation in the treatment of naive hypothyroid patients with Helicobacter pylori infection 156
Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes 155
Fighting obesity and associated risk factors by antagonising cannabinoid type 1 receptors. 154
The empowerment of translational research: lessons from laminopathies. 154
Psychological aspects of hyperandrogenic states in late adolescent and young women. 154
Cross-talk between adipose tissue and the HPA axis in obesity and overt hypercortisolemic states 153
Adrenal adenomas, subclinical hypercortisolism, and cardiovascular outcomes 152
Abdominal adiposity by ultrasonography: a "pocket" database for reference standard in Italian people 151
Clinical assessment of allostatic overload in adolescent and young women with hyperandrogenic states 150
Obesity-related proliferative diseases: The interaction between adipose tissue and estrogens in post-menopausal women 149
Energy balance regulation by endocannabinoids at central and peripheral levels 148
Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome. 147
Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study. 147
Salivary cortisol and cortisone responses to short-term psychological stress challenge in late adolescent and young women with different hyperandrogenic states 147
In vivo dissolution of levothyroxine soft gel capsules 145
Monogenic polycystic ovary syndrome due to a mutation in the lamin A/C gene is sensitive to thiazolidinediones but not to metformin 144
Common variants in the sex hormone-binding globulin gene (SHBG) and polycystic ovary syndrome (PCOS) in Mediterranean women. 144
Circulating obestatin levels and the grelin/obestatin ratio in obese women 144
Cannabinoid receptors as therapeutic targets for obesity and metabolic diseases. 142
Le aree cerebrali ed i neurotrasmettitori deputati al senso di sazietà, piacere e dipendenza: quale ruolo nel mantenimento dell'obesità? 141
EFFECT OF FASTING AND REFEEDING ON PLASMA GHRELIN LEVELS IN PREPUBERTAL GILTS 141
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group 141
Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. 140
Plasma acylated ghrelin levels are higher in patients with chronic atrophic gastritis. 140
No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours 140
Metabolic effects of obesity on reproduction. 138
Cannabinoid receptor antagonists and the metabolic syndrome: Novel promising therapeutical approaches. 138
La surrenectomia laparoscopica: le dimensioni della lesione costituiscono un limite all'approccio mini-invasivo? 137
Glucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: phenotype and associated factors 137
Increased clearance of cortisol by 5beta-reductase in a subgroup of women with adrenal hyperandrogenism in polycystic ovary syndrome. 137
Obesity, fat distribution and infertility. 136
Improving the diagnosis of 11β-hydroxylase deficiency using home-made MLPA probes: identification of a novel chimeric CYP11B2/CYP11B1 gene in a Sicilian patient 136
Prominent role of low HDL-cholesterol in explaining the high prevalence of the metabolic syndrome in polycystic ovary syndrome. 136
Plasma adiponectin in non alcoholic fatty liver disease is related to hepatic fat content and hepatic insulin resistance, not to liver disease severity 135
Metabolic alterations and cardiovascular risk factors in the polycystic ovary syndrome. 134
Hirsutism and virilization 134
Role of sex hormones in modulation of brown adipose tissue activity 134
Serum steroid profiling by isotopic dilution-liquid chromatography-mass spectrometry: comparison with current immunoassays and reference intervals in healthy adults. 134
Tissue-specific dysregulation of 11β-hydroxysteroid dehydrogenase type 1 in overweight/obese women with polycystic ovary syndrome compared with weight-matched controls 134
Revisiting hyper- and hypo-androgenism by tandem mass spectrometry. 133
Prescription medications for the treatment of obesity 133
Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome. 132
Heterogeneity in the responsiveness to long-term lifestyle intervention and predictability in obese women with polycystic ovary syndrome. 130
Ghrelin and reproductive disorders. 130
Maternal polycystic ovary syndrome may be associated with adverse pregnancy outcomes. 130
Peripheral endocannabinoid system-mediated actions of rimonabant on growth hormone secretion are ghrelin-dependent. 129
Clinical manifestations of PCOS 129
Stress-related development of obesity and cortisol in women 129
High serum concentration of total inhibin in polycystic ovary syndrome 129
Radiological formula for differentiating between secreting and non secreting adrenal adenomas. 129
Familial partial lipodystrophy, mandibuloacral dysplasia and restrictive dermopathy feature barrier-to-autointegration factor (BAF) nuclear redistribution 129
Obesity and androgens: facts and perspectives. 128
Sindrome dell'ovaio policistico e diabete di tipo 2 128
Human chorionic gonadotropin stimulation gives evidence of differences in testicular steroidogenesis in Klinefelter syndrome, as assessed by liquid chromatography-tandem mass spectrometry 128
Totale 16.854
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.385
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.385
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.912 0 0 0 0 0 199 53 190 259 191 140 880
2021/20223.732 386 148 250 307 320 204 94 249 123 249 831 571
2022/20233.381 421 477 168 478 182 209 102 170 542 217 248 167
2023/20241.362 101 167 64 44 63 164 256 359 20 57 43 24
2024/20253.414 134 695 336 226 675 200 205 72 41 133 81 616
2025/20264.290 585 723 797 677 964 544 0 0 0 0 0 0
Totale 27.085